http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0609251-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 |
| filingDate | 2006-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e42e08714af786f68aa8ce053da91f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64c64a58f0688333e28a2be9465c3a98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_083cbf977d7a39c313723e3afc8a22a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ca829667be394e7962f1fef88db8a48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf803be6567e682e0d229d0f83b7a964 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5efc5353787c2b28c613c96c90504786 |
| publicationDate | 2010-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0609251-A2 |
| titleOfInvention | piperidinyl piperazine derivatives useful as chemokine receptor inhibitors |
| abstract | PIPERIDINIL PIPERAZINE DERIVATIVES USEFUL AS INHIBITORS OF CHEMOCKIN RECEPTORS. In its many embodiments, the present invention provides a novel kiasis of compounds of formula IA or IR where R 1 1 -R 8 8 are as described herein Formula IA or IB as inhibitors of CCR5 receptors, methods of preparing these. compounds, pharmaceutical compositions containing one or more of these compounds, methods of preparing pharmaceutical formulations comprising one or more of these compounds, and methods of treating, preventing, inhibiting, or ameliorating one or more diseases associated with CCR5 using such compounds or compositions. The invention also relates to the use of a combination of a compound of this invention and one or more other antiviral agents useful in the treatment of human immunodeficiency virus (HIV). The invention further relates to the use of a compound of this invention, alone or in combination with another agent, in the treatment of solid organ transplant rejection, graft versus host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis. , psoriasis, asthma, allergies or multiple sclerosis. |
| priorityDate | 2005-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 358.